HIV Drug-Tipranavir

Thread View: bionet.biophysics

1 messages

[T] Back to Threads [V] Tree View [G] Group Articles

1 total messages Started by j_thomas Tue, 26 May 2009 03:26

#137

Author: j_thomas
Date: Tue, 26 May 2009 03:26

11 lines
1702 bytes

Tipranavir, or tipranavir disodium, is a nonpeptidic protease
inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade
name Aptivus. It is administered with ritonavir in combination therapy
to treat HIV infection.
Tipranavir has the ability to inhibit the replication of viruses that
are resistant to other protease inhibitors and it recommended for
patients who are resistant to other treatments. Resistance to
tipranavir itself seems to require multiple mutations.


http://bioinformations.info/?p=460

Thread Navigation

This is a paginated view of messages in the thread with full content displayed inline.

Messages are displayed in chronological order, with the original post highlighted in green.

Use pagination controls to navigate through all messages in large threads.

Back to All Threads